Trailing the advances made by AI in drug discovery, one can say there is a vast amount of untapped potential. Therapeutic nanobodies, particularly, have had relatively limited breakthroughs as they require complex interdisciplinary knowledge. The COVID-19 pandemic urged the development of therapeutic nanobodies that exhibit high binding affinity and stability for the SARS-CoV-2 in a […]
The post The Virtual Lab: AI Agents Design New SARS-CoV-2 Nanobodies with Experimental Validation appeared first on MarkTechPost.
SOCIAL SHARE CARD GENERATOR